Primaquine for Radical Cure ofPlasmodium vivaxandPlasmodium ovaleMalaria: An Observational Survey (2008–2010): Table 1 | Zendy

JeanFrançois Faucher | Zendy; AnnePauline Bellanger | Zendy; Catherine Chirouze | Zendy; Laurent HustacheMathieu | Zendy; Sandrine Genton | Zendy; Bruno Hoen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Primaquine for Radical Cure ofPlasmodium vivaxandPlasmodium ovaleMalaria: An Observational Survey (2008–2010): Table 1

Author(s) -

JeanFrançois Faucher,

AnnePauline Bellanger,

Catherine Chirouze,

Laurent HustacheMathieu,

Sandrine Genton,

Bruno Hoen

Publication year - 2013

Publication title -

journal of travel medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.985

H-Index - 59

eISSN - 1708-8305

pISSN - 1195-1982

DOI - 10.1111/jtm.12009

Subject(s) - primaquine , medicine , plasmodium ovale , plasmodium vivax , malaria , observational study , virology , immunology , plasmodium falciparum , chloroquine

Since 2008, the French guidelines have promoted the systematic use of 30 mg/day of primaquine for the radical cure of Plasmodium vivax and Plamodium ovale infections. We observed three relapses in 10 patients with P vivax acquired in French Guiana. No relapses were seen in West African P ovale patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research